Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Mologen AG. (3/14/18). "Press Release: Successful Capital Increase with Gross Proceeds of €4.99 Million [Not for release, publication or distribution in or into United States, Australia, Canada or Japan, or any other jurisditcion in which unlawful]". Ber

Organisations Organisation Mologen AG
  Group Mologen (Group)
  Organisation 2 Donau Invest Beteiligungs Ges.m.b.H.
Products Product lefitolimod (MGN1703)
  Product 2 venture capital
Index term Index term Mologen–SEVERAL: investment, 201802–20103 capital increase €4.99m with 2.36m new shares at €2.12/share to existing + new investors
Persons Person Miller, Walter (Mologen 201604– CFO before Nuvisan Gmbh + Santhera Pharmaceuticals)
  Person 2 Nickolaus, Claudia (Mologen 201407– Head Investor Relations)

Record changed: 2018-03-31


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Mologen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2018 Boston September 600x60px

» top